lobbying_activities: 2461798

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2461798	48a6ce69-439d-4ac9-a93f-d28fedade2b4	Q2	HOLLAND & KNIGHT LLP	18466	ALLIANCE FOR REGENERATIVE MEDICINE	2020	second_quarter	MMM	Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; "Value Based Payment" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748); Cures 2.0 legislative discussions.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2020-07-07T13:22:59.177000-04:00